Oxford University to investigate AZD1775 for bowel cancer

The UK's University of Oxford is set to investigate AstraZeneca ’s experimental drug AZD1775 in a new clinical trial for treatment of patients with bowel cancer.  

Source: Drug Development Technology - July 3, 2017 Category: Pharmaceuticals Source Type: news